Valeant Pharmaceuticals International

Type: Company
Name: Valeant Pharmaceuticals International
First reported 2 hours ago - Updated 2 hours ago - 1 reports

Predicting your pink slip

Share this article:Any time a firm needs to save money, high-salaried executives are targetsSander A. FlaumIt's not always easy to tell.  Of course, if you're the manager of a sports team with a 0-11 record, you might want to  be checking out Help Wanted ... [Published Medical Marketing And Media - 2 hours ago]
First reported 11 hours ago - Updated 11 hours ago - 1 reports

If Allergan Inc. Survives Valeant Pharmaceuticals International, AbbVie/or Actavis/May Be Suitors

September 30, 2014By Riley McDermid , BioSpace.com Breaking News Sr. EditorIf Botox maker Allergan Inc. ( AGN ) survives a hostile takeover attempt by larger rival Valeant Pharmaceuticals International ( VRX ), and manages to consummate its proposed deal ... [Published BioSpace - 11 hours ago]
First reported 13 hours ago - Updated 13 hours ago - 1 reports

TUSSICAPS (Hydrocodone Polistirex And Chlorpheniramine Polistirex) Capsule, Extended Release [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]

First reported 19 hours ago - Updated 13 hours ago - 2 reports

Allergan issues statement on Valeant offer, investor JSP voices concerns

Following various reporting and market speculation, including a letter from Allergan investor Jackson Square Partners, Allergan issued a statement from its board of directors reiterating its stance on the offer by Valeant Pharmaceuticals.“Our conclusion ... [Published Orthopedics Today - 13 hours ago]
First reported 19 hours ago - Updated 14 hours ago - 4 reports

Valeant Pharmaceuticals' New Jersey location gets FDA warning letter

By The Canadian Press | The Canadian Press – 10 minutes agoBusiness News »OTTAWA - Canada's broadcast regulator is hitting the 'delete' button on Netflix and Google, telling the online video services their submissions at hearings into the …TORONTO - Ernst ... [Published Yahoo! Canada - 14 hours ago]
First reported 19 hours ago - Updated 19 hours ago - 1 reports

Valeant's Bausch + Lomb Announces Results on Lotemax

Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight into ... [Published Zacks.com - 19 hours ago]
First reported 22 hours ago - Updated 22 hours ago - 1 reports

Levine on Wall Street: Contempt and Capture

Argentina is in contempt of court.U.S. District Judge Thomas Griesa has told Argentina that it can't pay interest on its bonds without first paying off holdout bondholders led by Elliott Management. Argentina disagrees, as is its right as a sovereign ... [Published Bloomberg View - 22 hours ago]
First reported Sep 29 2014 - Updated Sep 30 2014 - 15 reports

Allergan ordered to show business strategy documents

NEW YORK: Allergan’s attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers.On Monday, US District Judge David Carter of ... [Published The News International - Sep 30 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

Large-cap stocks across a variety of sectors continue to hold up relatively well amid increasing higher-volume declines in the major averages and overall market uncertainty. Valeant Pharmaceuticals (VRX) is a new entrant to this week's list. The drugmaker ... [Published Wall Street Business Network - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

CANADA STOCKS-TSX opens sharply lower; banks, Valeant lead retreat

TORONTO, Sept 29 (Reuters) - Canada's main stock index opened sharply lower on Monday, with the heavily weighted financial stocks and Valeant Pharmaceuticals International leading the retreat.The Toronto Stock Exchange's S&P/TSX composite index was down ... [Published Yahoo! Finance - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 2 reports

Allergan investors opposing Salix bid joined by Jackson Square

SAN FRANCISCO — Allergan investors voicing concern the maker of Botox may pursue a costly acquisition to fend off a $54 billion takeover bid by Valeant Pharmaceuticals International have been joined by Jackson Square Partners.Allergan's board shouldn't ... [Published SC Now - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

Valeant Pharmaceuticals appoints new director

Valeant Pharmaceuticals International, Inc., a developer of pharmaceutical products in the areas of dermatology, eye health, and neurology, has appointed Jeffrey Ubben as a director of the board, effective as of October 1, 2014. Mr Ubben is a Founder, ... [Published Individual.com - Sep 29 2014]

Quotes

I mean, that's how one of them went. All the other brokers were like, "Oh you don't want the money? Yeah we get that all the time, it's cool."
"Completing an acquisition prior to the special meeting will all but eliminate Allergan's alternatives for creating value. Limiting options is not in shareholders' interests" Jackson Square CEO Jeff Van Harte wrote in a Monday letter to Michael Gallagher, Allergan's lead independent director
"Cascade??? Of Biotech M&A Will Transform Specialty Pharma: Cowen"
...concern the corporate governance practices of the Allergan board," T Rowe spokesman Bill Benintende said in a statement seen by the news service. "The issues to be voted on at the special meeting of shareholders on Dec. 18 are of such importance that they impose a special duty on the board to refrain from approving any significant, irreversible commitments by the company between now and then unless shareholders are offered the opportunity to vote on them."

More Content

All (1846) | News (1078) | Reports (0) | Blogs (717) | Audio/Video (17) | Fact Sheets (2) | Press Releases (30)
sort by: Date | Relevance
Predicting your pink slip [Published Medical Marketing And Media - 2 hours ago]
If Allergan Inc. Survives Valeant Pharmaceutica... [Published BioSpace - 11 hours ago]
Hottest Healthcare Stocks Now – MASI VRX HLS KERX [Published InvestorPlace.com - 11 hours ago]
Accused Herbalife Insider Trader Tried to Take ... [Published Bloomberg View - 13 hours ago]
TUSSICAPS (Hydrocodone Polistirex And Chlorphen... [Published DailyMed Drug Label Updates for the last seven ... - 13 hours ago]
Allergan issues statement on Valeant offer, inv... [Published Orthopedics Today - 13 hours ago]
Valeant Pharmaceuticals' New Jersey location ge... [Published Yahoo! Canada - 14 hours ago]
Valeant Pharmaceuticals’ New Jersey location ge... [Published Canadian Business Magazine - 14 hours ago]
Valeant Pharmaceuticals' Bridgewater Location R... [Published Bio-Medicine - 18 hours ago]
Valeant Pharmaceuticals' Bridgewater Location R... [Published PR Newswire: Health - 19 hours ago]
Valeant's Bausch + Lomb Announces Results on Lo... [Published Zacks.com - 19 hours ago]
Allergan's next tug-of-war move: Attack Valeant... [Published FiercePharma - 19 hours ago]
Potential Valeant Pharmac. (VRX) Trade Has 6.22... [Published MarketIntelligenceCenter.com - 22 hours ago]
Levine on Wall Street: Contempt and Capture [Published Bloomberg View - 22 hours ago]
Allergan ordered to show business strategy docu... [Published The News International - Sep 30 2014]
ALLERGAN : Valeant Pharmaceuticals' third-quart... [Published 4 Traders - Sep 30 2014]
Allergan : Valeant Pharmaceuticals sees third-q... [Published 4 Traders - Sep 30 2014]
Valeant Pharmaceuticals sees third-quarter sale... [Published Reuters - Sep 30 2014]
Large-Cap Tech, Biotech Names Hang Tough In Sha... [Published Wall Street Business Network - Sep 29 2014]
Analysts Say Valeant Pharmaceuticals Internatio... [Published BioSpace - Sep 29 2014]
"Cascade??? Of Biotech M&A Will Transform Speci... [Published BioSpace - Sep 29 2014]
TSX Ends Lower On Global Concerns - Canadian Co... [Published RTTNews.com - Sep 29 2014]
Valeant Reasons, Ackman Threatens In Latest All... [Published Health News Daily - Sep 29 2014]
Rebound Efforts Fade For Stocks; Synchronoss Cl... [Published Investor's Business Daily - Sep 29 2014]
Wall Street falls amid Hong Kong unrest; pendin... [Published Proactive Investors USA - Sep 29 2014]
Canadian Stocks Drop Amid Geopolitical Risk [Published RTTNews.com - Sep 29 2014]
Allergan investors opposing Salix bid joined by... [Published SC Now - Sep 29 2014]
Allergan Investors Decry Possible Salix Deal [Published FINalternatives - Sep 29 2014]
5 Rocket Stocks to Buy to Avoid the Selloff [Published TheStreet.com - Sep 29 2014]
5 Rocket Stocks to Buy to Avoid the Selloff [Published The Street Latest - Sep 29 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
TUSSICAPS (Hydrocodone Polistirex And Chlorphen... [Published DailyMed Drug Label Updates for the last seven ... - 13 hours ago]
Updated Date: Sep 30, 2014 EST ...
Valeant Pharmaceuticals' Bridgewater Location R... [Published PR Newswire: Health - 19 hours ago]
LAVAL, Quebec, Sept. 30, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the company's Bridgewater, New Jersey location received a Warning Letter from the U.S. Food and Drug Administration ...
Potential Valeant Pharmac. (VRX) Trade Has 6.22... [Published MarketIntelligenceCenter.com - 22 hours ago]
After Monday’s trading in Valeant Pharmac. (VRX) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 6.42% or 44.20% (for comparison purposes only), while providing 6.22% downside protection. The trade is a Nov. ...
Potential Valeant Pharmac. (VRX) Trade Has 7.21... [Published MarketIntelligenceCenter.com - Sep 29 2014]
Valeant Pharmac. (VRX) traded between $126.99 and $129.66 before closing at $128.99 Friday and presents some attractive trading opportunities today. MarketIntelligenceCenter.com’s algorithms have picked a Nov. '14 $125.00 covered call for a net debit ...
Allergan Board of Directors Issues Statement [Published Business Wire Health News - Sep 29 2014]
IRVINE, Calif.--(BUSINESS WIRE)--The Board of Directors of Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today issued the following statement: There has recently been significant and potentially distracting market speculation regarding Allergan, ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Financial Stocks Help Lift The Major Indexes [Published Wall Street Journal What's News - Jun 17 2014]
Breakingviews: Snapchat for bankers? [Published Reuters Video: Top News - Jun 16 2014]
Breakingviews: Snapchat for bankers? [Published Reuters Video: Business - Jun 16 2014]
The Market Takes A Breather [Published Wall Street Journal What's News - Jun 10 2014]
Breakingviews: Valeant's deceptive carrot [Published Reuters Video: Business - Jun 02 2014]
1 2 3 4

Press Releases

sort by: Date | Relevance
Scanning Pharma Equities - Novo Nordisk, Teva P... [Published Financial Services - Sep 26 2014]
Regulatory Approvals, Senior Notes Redemption, ... [Published Financial Services - Sep 25 2014]
Increasing Demand for Skin Resurfacing Treatmen... [Published GlobeNewswire: Acquisitions News - Aug 25 2014]
Termination of Waiting Period, Appointment, Ext... [Published Financial Services - Aug 22 2014]
Pharma Stocks Review -- Eli Lilly, Zogenix, Gla... [Published Financial Services - Aug 21 2014]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.